Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HODGKIN LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06208735
What this trial is testing

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Who this might be right for
B-Cell LeukemiaNon-Hodgkin's LymphomaB-cell Acute Lymphoblastic Leukemia+5 more
British Columbia Cancer Agency 24
Testing effectiveness (Phase 2)Looking for participantsNCT04961515
What this trial is testing

Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Hodgkin Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 19
Post-approval studies (Phase 4)Study completedNCT01982539
What this trial is testing

Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

Who this might be right for
Pain
Depomed 25
Testing effectiveness (Phase 2)UnknownNCT03337919
What this trial is testing

ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University College, London 78
Not applicableUnknownNCT05772728
What this trial is testing

Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)

Who this might be right for
T Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 23
Testing effectiveness (Phase 2)UnknownNCT04648475
What this trial is testing

Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma

Who this might be right for
Leukemia, B-cellLymphoma, B-Cell
Chongqing Precision Biotech Co., Ltd 40
Testing effectiveness (Phase 2)Looking for participantsNCT06918912
What this trial is testing

Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure

Who this might be right for
Diffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma (HGBCL)B-Cell Lymphoma Treatment+1 more
Istituto Clinico Humanitas 50
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT07013565
What this trial is testing

Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-Positive
New York Medical College 20
Not applicableLooking for participantsNCT05444712
What this trial is testing

Transplantation After Complete Response In Patients With T-cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Hospices Civils de Lyon 204
Testing effectiveness (Phase 2)Ended earlyNCT00722865
What this trial is testing

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT05909059
What this trial is testing

CAR T-cell Therapy in Patients With Renal Dysfunction

Who this might be right for
Non-hodgkin Lymphoma,B CellMultiple MyelomaAcute Lymphoblastic Leukemia, Adult
Northside Hospital, Inc. 20
Early research (Phase 1)Study completedNCT03424603
What this trial is testing

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

Who this might be right for
B-cell LymphomaNon Hodgkin LymphomaMultiple Myeloma+5 more
Sutro Biopharma, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT00193505
What this trial is testing

Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC 40
Not applicableLooking for participantsNCT06785324
What this trial is testing

Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Philadelphia Chromosome NegativeB Cell Acute Lymphoblastic Leukemia (B-ALL)B-ALL
University of Chicago 20
Testing effectiveness (Phase 2)Looking for participantsNCT06043323
What this trial is testing

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02797470
What this trial is testing

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

Who this might be right for
HIV InfectionMature T-Cell and NK-Cell Non-Hodgkin LymphomaPlasmablastic Lymphoma+8 more
AIDS Malignancy Consortium 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT06939283
What this trial is testing

A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Hodgkin Lymphoma
Werewolf Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00646750
What this trial is testing

Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom

Who this might be right for
Non-Hodgkin's Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 31
Not applicableStudy completedNCT06777290
What this trial is testing

Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma

Who this might be right for
Lymphoma, Diffuse Large B-Cell
Charles University, Czech Republic 14
Next Page